Search
Friday 2 October 2015
  • :
  • :
Latest Update

News Analysis on: ONEOK, Inc.(NYSE:OKE), Ally Financial Inc(NYSE:ALLY), Baxalta Inc(NYSE:BXLT), Penn Virginia Corporation(NYSE:PVA)

On Friday, ONEOK, Inc. (NYSE:OKE)’s shares declined -0.76% to $35.40.

ONEOK, Inc. (OKE) and ONEOK Partners, L.P. (OKS) will take part at the Barclays CEO Energy Conference Sept. 8-9, 2015 in New York City.

Terry K. Spencer, ONEOK and ONEOK Partners president and chief executive officer, will present at the conference at 1:45 p.m. Eastern Daylight Time (12:45 p.m. Central Daylight Time) on Tuesday, Sept. 8.

Spencer and Walter S. Hulse III, ONEOK and ONEOK Partners executive vice president of planned planning and corporate affairs, also will conduct a series of one-on-one meetings with investment-community representatives at the conference.

ONEOK, Inc., through its general partner interests in ONEOK Partners, L.P., engages in the gathering, processing, storage, and transportation of natural gas in the United States. The company gathers, treats, fractionates, stores, and transports natural gas liquids (NGL), in addition to owns natural gas liquids gathering and distribution pipelines, natural gas liquids distribution and refined petroleum products pipelines, and terminal and storage facilities; and owns and operates interstate and intrastate regulated natural gas transmission pipelines and natural gas storage facilities, in addition to stores and distributes NGL products to petrochemical manufacturers, heating fuel users, ethanol producers, refineries, and propane distributors.

Ally Financial Inc (NYSE:ALLY)’s shares gained 0.05% to $20.58.

Ally Financial Inc. (ALLY) declared that it will conduct its 2016 annual meeting of stockholders on Tuesday, May 3, 2016 at 9 a.m. ET in Detroit, Michigan. Additional details will be offered in the company’s proxy statement.

Under SEC Rule 14a-8, a shareholder who intends to present a proposal at the 2016 annual meeting and who wishes the proposal to be comprised of in the proxy statement for that meeting must submit the proposal in writing to the Corporate Secretary of Ally Financial at 200 Renaissance Center, Mail Code 482-B09-C24, Detroit, Michigan 48265. The proposal must be received no later than December 10, 2015. The proposal must satisfy all applicable requirements of Rule 14a-8 and the company’s bylaws.

Ally Financial Inc. provides financial products and services primarily to automotive dealers and their customers in the United States. It offers dealer financial services, counting a range of financial services and insurance products to automotive dealers and retail customers. The company also provides automotive finance services, such as new and used vehicle inventory financing; inventory insurance; term loans, counting real estate and working capital loans; and vehicle remarketing services, in addition to vehicle service contracts (VCSs) and guaranteed automobile protection (GAP) products.

At the end of Friday’s trade, Baxalta Inc (NYSE:BXLT)‘s shares dipped -0.22% to $36.08.

Baxalta Incorporated (BXLT) declared it has filed a Registration Statement on Form S-1 with the Securities and Exchange Commission (SEC) recently in connection with the projected secondary offering of up to $1.45 billion of common stock of the company presently held by Baxter International Inc. (BAX). J.P. Morgan Securities LLC is acting as the sole underwriter for the offering.

The projected offering is comprising with the formerly revealed plan of Baxter to engage in certain debt-for-equity exchanges to dispose of its retained stake in Baxalta in a tax-free manner within the 18-month period following Baxalta’s separation from Baxter. Baxalta is not selling any shares in the offering and will not receive any proceeds from the offering.

Baxalta Incorporated, a biopharmaceutical company, develops, manufactures, and markets a portfolio of products primarily for the treatment of hematology and immunology worldwide. It also offers other therapies for the treatments of bleeding disorders, and chronic and acute medical conditions, counting hemophilia A, hemophilia B, attained hemophilia, inhibitor treatments, primary immunodeficiency (PID), and alpha-1 antitrypsin deficiency.

Penn Virginia Corporation (NYSE:PVA), ended its Friday’s trading session with -3.57% loss, and closed at $1.08.

Penn Virginia Corporation (PVA) declared that it has closed the formerly declared sale of its East Texas assets. The net cash proceeds from the sale were about $74 million, counting customary closing adjustments.

Pro forma for the East Texas divestiture, at June 30, 2015, our total debt ratio and credit exposure ratio, defined as all outstanding borrowings under our revolving credit facility (Revolver) plus any outstanding letters of credit, were 3.6 times and 0.4 times trailing twelve months’ pro forma Adjusted EBITDAX, respectively, with $138 million outstanding under our revolving Revolver and financial liquidity of $259 million. This compares to total debt and credit exposure ratios of 3.7 times and 0.6 times, respectively, with $212 million outstanding under the Revolver and financial liquidity of $215 million as of June 30, 2015.

Penn Virginia Corporation, an independent oil and gas company, explores, develops, and produces crude oil, natural gas liquids, and natural gas in various onshore regions of the United States. The company’s operations comprise the drilling of unconventional horizontal development wells in the Eagle Ford Shale in South Texas. It also has operations in the Granite Wash in Oklahoma, and the Haynesville Shale and Cotton Valley in East Texas.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *